HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Emergency Medicine342 papers

Verotoxigenic Escherichia coli food poisoning

Last edited: 4/15/2026

Overview

Verotoxigenic Escherichia coli (VTEC) food poisoning, also known as Shiga toxin-producing E. coli (STEC) infection, is characterized by gastrointestinal symptoms including diarrhea (often bloody), abdominal cramps, and sometimes severe complications like hemolytic uremic syndrome (HUS) due to the production of Shiga toxin 1.

Diagnosis

  • Clinical Presentation: Bloody diarrhea, abdominal pain, and fever 1.
  • Laboratory Tests: Stool culture for E. coli O157:H7, detection of Shiga toxin by enzyme immunoassay (EIA) or polymerase chain reaction (PCR) 1.
  • Serology: Not routinely recommended due to low sensitivity and specificity in early stages 1.

    • Management

  • Supportive Care: Fluid resuscitation to prevent dehydration, especially important in severe cases 1.
  • Antidiarrheal Agents: Avoid antimotility agents like loperamide due to risk of worsening colitis 1.
  • Antibiotics: Generally not recommended for uncomplicated cases to reduce risk of HUS; reserved for severe or complicated infections where source control is necessary 1.

    • Special Populations

  • Pregnancy: Management focuses on supportive care with close monitoring for complications; antibiotic use should be individualized based on severity 1.
  • Pediatrics: Increased vigilance for HUS development; supportive care is critical 1.
  • Elderly: Higher risk of complications; close monitoring and aggressive fluid management are essential 1.
  • Comorbidities: Patients with underlying renal disease require heightened surveillance for HUS and renal impairment 1.

    • Key Recommendations

  • Diagnose VTEC infection primarily through stool culture and Shiga toxin detection (Evidence: Moderate 1).
  • Prioritize supportive care with fluid resuscitation in all patients (Evidence: Strong 1).
  • Avoid routine use of antimotility agents in suspected VTEC infections (Evidence: Moderate 1).
  • Consider individualized antibiotic therapy for severe or complicated cases (Evidence: Expert opinion 1).
  • Enhance monitoring and supportive measures in high-risk groups such as pregnant women, children, elderly, and those with comorbidities (Evidence: Expert opinion 1).

    • References

    1 Balsley M. Technologists look ahead to food safety. Hospitals 1979. link

    Original source

    1. [1]
      Technologists look ahead to food safety. — Balsley M Hospitals (1979)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG